FI54289B - Foerfarande foer framstaellning av terapeutiskt aktiva bisfenoxikarboxylsyraderivat - Google Patents

Foerfarande foer framstaellning av terapeutiskt aktiva bisfenoxikarboxylsyraderivat

Info

Publication number
FI54289B
FI54289B FI142572A FI142572A FI54289B FI 54289 B FI54289 B FI 54289B FI 142572 A FI142572 A FI 142572A FI 142572 A FI142572 A FI 142572A FI 54289 B FI54289 B FI 54289B
Authority
FI
Finland
Prior art keywords
syraderivat
bisphenoxic
carboxyl
active
frequency requirement
Prior art date
Application number
FI142572A
Other languages
English (en)
Other versions
FI54289C (fi
Inventor
Yoshio Suzuki
Masayoshi Minai
Noritaka Hamma
Eiichi Murayama
Shunji Aono
Original Assignee
Sumitomo Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP3486671A external-priority patent/JPS5030613B1/ja
Priority claimed from JP3486771A external-priority patent/JPS5020056B1/ja
Application filed by Sumitomo Chemical Co filed Critical Sumitomo Chemical Co
Application granted granted Critical
Publication of FI54289B publication Critical patent/FI54289B/fi
Publication of FI54289C publication Critical patent/FI54289C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/46Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182Radicals derived from carboxylic acids
    • C07D295/185Radicals derived from carboxylic acids from aliphatic carboxylic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI142572A 1971-05-22 1972-05-19 Foerfarande foer framstaellning av terapeutiskt aktiva bisfenoxikarboxylsyraderivat FI54289C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP3486671A JPS5030613B1 (fi) 1971-05-22 1971-05-22
JP3486771A JPS5020056B1 (fi) 1971-05-22 1971-05-22

Publications (2)

Publication Number Publication Date
FI54289B true FI54289B (fi) 1978-07-31
FI54289C FI54289C (fi) 1978-11-10

Family

ID=26373738

Family Applications (1)

Application Number Title Priority Date Filing Date
FI142572A FI54289C (fi) 1971-05-22 1972-05-19 Foerfarande foer framstaellning av terapeutiskt aktiva bisfenoxikarboxylsyraderivat

Country Status (13)

Country Link
BE (1) BE783702A (fi)
CA (1) CA976160A (fi)
CH (1) CH577460A5 (fi)
DD (1) DD97652A5 (fi)
DE (1) DE2224594A1 (fi)
DK (1) DK135420B (fi)
FI (1) FI54289C (fi)
FR (1) FR2138687B1 (fi)
GB (1) GB1356747A (fi)
HU (1) HU163355B (fi)
NL (1) NL148043B (fi)
NO (1) NO136249C (fi)
SE (1) SE385472B (fi)

Also Published As

Publication number Publication date
DK135420B (da) 1977-04-25
DE2224594A1 (de) 1973-01-18
DK135420C (fi) 1977-10-10
CH577460A5 (fi) 1976-07-15
GB1356747A (fi) 1974-06-12
DE2224594B2 (fi) 1975-05-07
NL7206316A (fi) 1972-11-24
NO136249B (fi) 1977-05-02
SE385472B (sv) 1976-07-05
FI54289C (fi) 1978-11-10
NO136249C (no) 1977-08-10
CA976160A (en) 1975-10-14
BE783702A (fr) 1972-09-18
FR2138687A1 (fi) 1973-01-05
DE2224594C3 (fi) 1975-12-18
HU163355B (fi) 1973-07-28
NL148043B (nl) 1975-12-15
DD97652A5 (fi) 1973-05-12
FR2138687B1 (fi) 1975-10-17

Similar Documents

Publication Publication Date Title
FI55997B (fi) Foerfarande foer framstaellning av terapeutiskt aktiva 1 4-dihydrokarboxylsyraestrar
NO140381C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive arylpiperaziner
NO137440C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pleuromutiliner
NO137694C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner
NO142033C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive isopropylamino-3-fenoksypropanoler
NO138999C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive difenylyl-alkanoylaminopyridiner
NO144153C (no) Fremgangsmaate for fremstilling av delta3-7-acylamido-3-metyl-cefem-4-karboksylsyrer
SE400551B (sv) Forfarande for framstellning av terapeutiskt aktiva 3-amino-5-karbamylbensoesyraderivat
NO137858C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indanoner
NO143064C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksyalkylxantiner
NO142077C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-(1-cyclohexyl-3-pyrrolidinyl)-benzamider
FI55988C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara o-acylfenoletanolaminer
FI56834B (fi) Foerfarande foer framstaellning av terapeutiskt aktiva bensensulfonylkarbamid
FI783924A (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 5- eller 7-substituerade xanton-2-karboxylsyrafoereningar
FI55505C (fi) Foerfarande foer framstaellning av terapeutiskt aktiva 2-kinoxalinkarboxiamid-1 4-dioxider
FI55513C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara alfa-acyloxialkylpenicilliner
FI53819C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara n-lysergyl-3-aminopyridiner
FI56371B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara bensoylestrar av 1,8,9-trihydroxiantracen
FI54289B (fi) Foerfarande foer framstaellning av terapeutiskt aktiva bisfenoxikarboxylsyraderivat
FI54710B (fi) Foerfarande foer framstaellning av nya terapeutiskt aktiva 6-aza-3h-1,4-bensodiazepiner
FI56179C (fi) Foerfarande foer framstaellning av terapeutiskt verksamma imidazolderivat
NO137893C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-m-trifluormetylfenyl-2-cyanoalkylaminopropaner
NO137727C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-fenyl-3-hydroksy-3-metyltriazener
FI56171C (fi) Foerfarande foer framstaellning av terapeutiskt aktiva asylerade piperidin- tetrahydropyridin- och pyridinderivat
SE393616B (sv) Forfarande for framstellning av dihydrokodein